SIBN
$12.84
SI-BONE, Inc., a medical device company, develops procedural solutions for compromised bone, grounded in expertise in biomechanical design and anatomy-specific applications in the United States and internationally.
Historical Price
Peer Comparison
Whystock Valuation Model
Fundamentals
SI-BONE, Inc., a medical device company, develops procedural solutions for compromised bone, grounded in expertise in biomechanical design and anatomy-specific applications in the United States and internationally. It offers a series of patented tita...
Recent News
Jim Cramer on SI-BONE, Inc.: “We’re Not Going to Buy the Money Losers”
SI-BONE, Inc. (NASDAQ:SIBN) is one of the stocks Jim Cramer answered questions about. Inquiring about the stock, a caller mentioned that it has declined around 30% since they last asked about it in January. In response, Cramer said: Gee, I don’t know. That’s, whoa, they’re losing too much money. We’re in a tough tape. We’re […]
SI-BONE, Inc. Q4 2025 Earnings Call Summary
Moby summary of SI-BONE, Inc.'s Q4 2025 earnings call
Smith+Nephew, SI-BONE partner to distribute iFuse TORQ portfolio
The iFuse TORQ portfolio includes the iFuse TORQ TNT and iFuse TORQ implants.
SI-BONE Inc (SIBN) Q4 2025 Earnings Call Highlights: Record Revenue and Strategic Partnerships ...
SI-BONE Inc (SIBN) reports robust revenue growth and strategic initiatives, setting the stage for continued expansion in 2026 despite anticipated challenges.
Si-Bone (SIBN) Reports Q4 Loss, Tops Revenue Estimates
Si-Bone (SIBN) delivered earnings and revenue surprises of +69.23% and +0.09%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?